cell-therapy

Documents about cell-therapy

• Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy#442079ClinicalTrials.gov
• T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.#802603ClinicalTrials.gov
• A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer#831903ClinicalTrials.gov
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer#840354ClinicalTrials.gov
• A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer#851226ClinicalTrials.gov
• Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck#853182ClinicalTrials.gov
• Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy#858807ClinicalTrials.gov
• A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)#859630ClinicalTrials.gov
• An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer#861045ClinicalTrials.gov
• Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin#208448ClinicalTrials.gov
• Synergistic Sono-Chemodynamic Therapy of Renal Cell Carcinoma Using HKUST-1@TiO(2) Heterojunctions.#138438NCBI PubMed Central
• Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy#224961OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Heterogeneity of macrophages in PD-1/PD-L1 inhibitor therapy: a single-cell perspective.#288709NCBI PubMed Central
• Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma#411246ClinicalTrials.gov
• Restoring neuroplasticity after CNS trauma: cell therapy approaches in spinal cord and traumatic brain injury.#472735NCBI PubMed Central
• Functional Heterogeneity of Immune Cell Subpopulations in Atherosclerosis: From Basic Mechanisms to Precision Therapy.#653384NCBI PubMed Central
• Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy#847741ClinicalTrials.gov
• Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients#857238ClinicalTrials.gov
• REACT-01: Reversing Autoimmunity Through Cell Therapy#862740ClinicalTrials.gov
• Multimodal Prehabilitation in Patients with Lung Cancer Undergoing Neoadjuvant Therapy#863802ClinicalTrials.gov
• Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC#801961ClinicalTrials.gov
• Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma#804436ClinicalTrials.gov
• The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo#843647ClinicalTrials.gov
• A descriptive study assessing the effectiveness of patient blood management initiatives at a tertiary level hospital in South Africa by comparing the utilisation of iron therapy (oral and intravenous) to packed red blood cell transfusions over a 10-Year period#331219OpenUCT
• Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer#839217ClinicalTrials.gov
• Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#839762ClinicalTrials.gov
• A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies#314331ClinicalTrials.gov
• Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma#811040ClinicalTrials.gov
• Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery#812536ClinicalTrials.gov
• Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)#835765ClinicalTrials.gov
• Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#837694ClinicalTrials.gov
• Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy#804408ClinicalTrials.gov
• Rational design of protein switches: applications in synthetic biology and cancer immunotherapy#179003Infoscience
• Hybrid-delivered cognitive behavioral symptom management and activity coaching intervention for patients following hematopoietic stem cell transplant or CAR T-cell therapy: Protocol of a randomized controlled trial.#193509NCBI PubMed Central
• Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer#287530ClinicalTrials.gov
• Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma#342177HAL (France)
• Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy#378003HAL (France)
• Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease#806445ClinicalTrials.gov
• Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)#807736ClinicalTrials.gov
• Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus#813961ClinicalTrials.gov
• A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma#833940ClinicalTrials.gov
• The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)#855053ClinicalTrials.gov
• Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma#857449ClinicalTrials.gov
• GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma#394612ClinicalTrials.gov
• Lymphocyte Depletion and Change in Lymphocyte Functionality#804372ClinicalTrials.gov
• Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial#810295ClinicalTrials.gov
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed#834109ClinicalTrials.gov
• Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry#239043HAL (France)
• CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)#861685ClinicalTrials.gov
• The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer#146444ClinicalTrials.gov